Shoulder Innovations Inc

SI

Market cap $299M

Shoulder Innovations posted a wider-than-expected loss in Q3, but sales crushed expectations. The company also raised its full-year sales guidance.

GRAND RAPIDS, Mich. , Nov. 11, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the third quarter ended September 30, 2025.

GRAND RAPIDS, Mich. , Nov. 4, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that Rob Ball, CEO, will present at the upcoming Jefferies Global Healthcare Conference.

GRAND RAPIDS, Mich. , Oct. 20, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the third quarter of 2025 after market close on Tuesday, November 11, 2025.

Expansion of the I-Series Humeral Stem Product Line Further Strengthens Robust Shoulder Arthroplasty Portfolio GRAND RAPIDS, Mich. , Sept. 22, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the full commercial launch of the InSet™ 70 Humeral Stem ("InSet™ 70").

Company to Participate in a Fireside Chat at the Morgan Stanley 23 rd Annual Global Healthcare Conference Today at 8:30 a.m. ET GRAND RAPIDS, Mich.

Company to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on the Same Day GRAND RAPIDS, Mich. , Aug. 28, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the second quarter of 2025 before market open on Tuesday, September 9, 2025.

Shoulder Innovations IPO priced below range, reflecting investor caution as revenue growth slows sharply despite strong prior expansion. Valuation is modest at 3-4x sales, supported by a substantial net cash position, but ongoing operating losses remain a concern. Key risks include product concentration, regulatory challenges, and fierce competition from established medtech giants like J&J and Stryker.

Six IPOs and one SPAC debuted this week. Nine IPOs and two SPACs submitted initial filings this week. Two sizable mining companies are slated to go public in the US in the week ahead.

Shoulder Innovations, Inc. has filed to raise $100 million in a U.S. IPO. The company is targeting the shoulder arthroplasty market, leveraging proprietary technology and a specialized commercial team, but faces intense competition and potential scaling risks. IPO proceeds will fund commercial expansion, R&D, and working capital, with management expecting funds to last at least 12 months post-offering.